4//SEC Filing
Swartz Robin 4
Accession 0001104659-24-131725
CIK 0001640266other
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 4:29 PM ET
Size
5.4 KB
Accession
0001104659-24-131725
Insider Transaction Report
Form 4
Swartz Robin
COO & CBO
Transactions
- Sale
Common Stock
2024-12-23$5.65/sh−6,500$36,725→ 112,328 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.62 to $5.70, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]Includes 1,824 shares of common stock acquired under the Voyager Therapeutics, Inc. 2015 Employee Stock Purchase Plan on June 28, 2024.
Documents
Issuer
Voyager Therapeutics, Inc.
CIK 0001640266
Entity typeother
Related Parties
1- filerCIK 0001909636
Filing Metadata
- Form type
- 4
- Filed
- Dec 25, 7:00 PM ET
- Accepted
- Dec 26, 4:29 PM ET
- Size
- 5.4 KB